Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study Journal Articles Refereed uri icon

Overview

Published in

  • Lancet Oncology

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1016/s1470-2045(16)30631-3

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 18

Issue

  • 1

Publisher

  • Lancet